ArticleMolecular cancer2025

Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma.

Anyu Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.